By means of phase-sensitive techniques it is possible to generate contrast also in relation to the phase shifts imparted by the sample and to extend the capabilities of X-ray imaging to those details that lack enough absorption contrast to be visualised in conventional radiography.
The results from a pilot study focusing on cured-in-place pipe (CIPP) rehabilitation technologies were previously reported and the research program was extended to allow collection of additional CIPP samples and also to extend the study to other rehabilitation technologies (specifically included in this Phase 2 research were fold-and-form, deform reform, and sliplining technologies).
Research involving more representative samples is needed to extend our understanding of the broader impact of obesity in hip or knee joint disease (arthritis and OA) beyond clinical settings.
Research using more representative samples is needed to extend our understanding of the personal impact of concurrent obesity and hip or knee joint disease beyond primary care and outpatient settings.
It is typically approached by position weight matrix-based motif identification algorithms using Gibbs sampling, or heuristics to extend seed oligos.
The sample size of 200 was chosen to allow a two-sided 95% Confidence Interval (CI) for a single proportion (e.g., the proportion of patients discharged from the clinic), using the large sample normal approximation, to extend 7.1% from the most conservative proportion of 50%, while allowing for a 5% patient exclusion rate.
For the add a branch move, a time point is empirically sampled and proposed to extend backward a length of k 1 ∼ 1 + Poisson (λ 1 ) in time using standard MCMC methods to update the parameters for each individual time point.
Thus, the peculiarity of the selected sample limits the possibility to extend the conclusions reached by this research, which should be tested on a sample of innovative firms of different origins.
Given that neurological soft signs are also demonstrated in healthy, non-clinical samples, and non-psychotic relatives of patients with schizophrenia [2], [30] [34], and the observable variations of neurocognitive performances between clinical and non-clinical samples, e.g., it is worthwhile to extend such an investigation to non-clinical samples [35].
The company also claimed that the auditors based their findings on a sample of documents and did not seek to extend the sample size.
